Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook

RE: “Structural Racism in Newborn Drug Testing: Perspectives of Health Care and Child Protective Services Professionals” by Shetty et al

  • Naomi S Kasturiarachi, Family Medicine Resident Physician, OhioHealth Riverside Methodist Hospital
20 August 2024

“Structural Racism in Newborn Drug Testing: Perspectives of Health Care and Child Protective Services Professionals” shares a thorough qualitative analysis of how structural racism via disproportionate substances testing and subsequent child protective service (CPS) referrals impacts Black families. [1] Marijuana is a frequently highlighted substance in the article’s study. Black families were disproportionately tested for marijuana, leading to higher positive screens and negative downstream ramifications. The recent federal decriminalization of marijuana should be considered when enacting policy regarding substance testing. Doing so may aid in deconstructing racist policy for Black birthing families.

19% of Americans have used marijuana at least once. [2] Marijuana was disproportionately screened for in Black birthing families, though the article has shown that their white counterparts use it just as frequently. In May 2024, the federal government moved to decriminalize marijuana from a Schedule I to Schedule III substance. [3] Tobacco has similar prenatal risks compared to marijuana. Both substances are associated with increased rates of neonatal intensive care unit admissions, lower APGAR scores, lower birth rates, and higher incidence of stillbirths. [4] Since there is no national standard of policy that recommends substance testing on intrauterine tobacco exposure, there should not be for marijuana either. Current American College of Obstetrics and Gynecology recommendations are simply to screen for tobacco use during pregnancy and to assist with cessation. [5] Marijuana use can be treated similarly, which would lead to decreased discriminatory substance testing and subsequent CPS referrals that place undue bias against Black birthing families.

With the decriminalization of marijuana, our efforts should focus on encouraging cessation with structured resources rather than punitive action with biased substance testing. Evidence-based interventions may include patient-centered motivational interviewing and cognitive behavioral therapy sessions. Shifting hospital policies to focus on support will overall reduce discriminatory CPS referrals for Black families. These actions will aid in the dismantling of racist policies in the newborn nursery.
 
References
1. Shetty, Carol, et al. “Structural Racism in Newborn Drug Testing: Perspectives of Health Care and Child Protective Services Professionals.” The Annals of Family Medicine, vol. 22, no. 4, 1 July 2024, pp. 271–278, www.annfammed.org/content/22/4/271, https://doi.org/10.1370/afm.3139.
2. Substance Abuse and Mental Health Services Administration. “2021 NSDUH Annual National Report | CBHSQ Data.” Www.samhsa.gov, 4 Jan. 2023, www.samhsa.gov/data/report/2021-nsduh-annual-national-report.
3. “U.S. Drug Enforcement Administration Proposes Reclassification of Marijuana | Insights | Holland & Knight.” Www.hklaw.com, www.hklaw.com/en/insights/publications/2024/05/us-drug-enforcement-admin....
4. Zoorob, Roger, and Jeffrey D. Quinlan. “Cannabis Use during Pregnancy.” Family Practice Management, vol. 31, no. 4, 2024, pp. 19–21, www.aafp.org/pubs/fpm/issues/2024/0700/cannabis-during-pregnancy.html.
5. “Tobacco and Nicotine Cessation during Pregnancy.” Www.acog.org, www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/...

Competing Interests: None declared.
See article »

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine